Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Abeona Therapeutics Inc. (ABEO)

Compare
4.6000
+0.4200
+(10.05%)
At close: April 11 at 4:00:01 PM EDT
4.6199
+0.02
+(0.43%)
After hours: April 11 at 7:54:56 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
3,500
1,414
3,000
Cost of Revenue
--
--
1,605
450
--
Gross Profit
--
--
1,895
964
3,000
Operating Expense
64,211
64,211
50,095
46,221
60,370
Operating Income
-64,211
-64,211
-48,200
-45,257
-57,370
Net Non Operating Interest Income Expense
38
38
1,699
-305
-3,616
Other Income Expense
439
439
-7,687
5,866
-23,950
Pretax Income
-63,734
-63,734
-54,188
-39,696
-84,936
Net Income Common Stockholders
-63,734
-63,734
-54,188
-43,478
-84,936
Diluted NI Available to Com Stockholders
-63,734
-63,734
-54,188
-43,478
-84,936
Basic EPS
-2.05
-1.55
-2.53
-5.53
-21.50
Diluted EPS
-2.05
-1.55
-2.53
-5.53
-21.50
Basic Average Shares
35,301.7210
41,048.2060
21,380.4760
7,861.5150
3,937.6760
Diluted Average Shares
35,301.7210
41,048.2060
21,380.4760
7,861.5150
3,937.6760
Total Operating Income as Reported
-64,211
-64,211
-47,135
-50,915
-89,836
Total Expenses
64,211
64,211
51,700
46,671
60,370
Net Income from Continuing & Discontinued Operation
-63,734
-63,734
-54,188
-39,696
-84,936
Normalized Income
-62,979
-62,979
-43,558
-45,421
-60,971
Interest Income
4,246
4,246
2,117
431
40
Interest Expense
4,208
4,208
418
736
3,656
Net Interest Income
38
38
1,699
-305
-3,616
EBIT
-59,526
-59,526
-53,770
-38,960
-81,280
EBITDA
-56,619
-56,619
-50,572
-34,383
-76,816
Reconciled Cost of Revenue
--
--
1,605
450
--
Reconciled Depreciation
2,907
2,907
3,198
4,577
4,464
Net Income from Continuing Operation Net Minority Interest
-63,734
-63,734
-54,188
-39,696
-84,936
Total Unusual Items Excluding Goodwill
-755
-755
-10,630
5,725
-23,965
Total Unusual Items
-755
-755
-10,630
5,725
-23,965
Normalized EBITDA
-55,864
-55,864
-39,942
-40,108
-52,851
12/31/2021 - 9/19/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MIST Milestone Pharmaceuticals Inc.
0.7713
+2.84%
 
ALDX Aldeyra Therapeutics, Inc.
1.9100
+1.06%
 
ATRA Atara Biotherapeutics, Inc.
5.53
+4.34%
 
KALV KalVista Pharmaceuticals, Inc.
11.49
+9.01%
 
GRCE Grace Therapeutics, Inc.
1.9799
+1.02%
 
UNCY Unicycive Therapeutics, Inc.
0.5476
+3.30%
 
NUVB Nuvation Bio Inc.
1.9900
+13.71%
 
SCPH scPharmaceuticals Inc.
2.3200
+15.14%
 
FDMT 4D Molecular Therapeutics, Inc.
2.6300
+1.54%
 
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%